NCT03229785 is a Phase 1 clinical trial of Human Umbilical Cord Blood Plasma in Aging, sponsored by Hexagon Therapies, LLC.

Who is sponsoring NCT03229785?

NCT03229785 is sponsored by Hexagon Therapies, LLC.

What drugs are being tested in NCT03229785?

Interventions in NCT03229785: Human Umbilical Cord Blood Plasma.

Is NCT03229785 still recruiting?

NCT03229785 is currently status unknown. Last updated 24 January 2018.

Last reviewed 2018-01-24 · How we verify

NCT03229785

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Life Improvements With Cord Blood Plasma

Status unknown Phase 1 Last updated 24 January 2018

What this trial tests

Phase 1 trial testing Human Umbilical Cord Blood Plasma in Aging in 200 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
31 January 2019

1 August 2019

Quick facts

Lead sponsor	Hexagon Therapies, LLC
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	200
Start date	1 April 2018
Primary completion	31 January 2019
Estimated completion	1 August 2019

Drugs / interventions tested

Human Umbilical Cord Blood Plasma — full drug profile →

Conditions studied

Aging — all drugs for Aging →

Sponsor

Hexagon Therapies, LLC — full company profile →

Who can join

Adults 50 to 80, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to look at whether human umbilical cord blood plasma (HUCBP) is safe for intravascular (iv) administration; and whether it provides any reversal of frailty or other age-related biological measures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Role of Blood-Derived Factors in Protection and Regeneration of Aged Tissues.
Höving AL, Schmidt KE, Kaltschmidt B, Kaltschmidt C, et al · · 2022 · cited 8× · PMID 36077021 · DOI 10.3390/ijms23179626

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03229785 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hexagon Therapies, LLC
Last refreshed: 24 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03229785.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing